These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1476539

  • 21. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Murphy DL.
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [Abstract] [Full Text] [Related]

  • 22. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E, Mullen L, DeCaria CM, Skodol A, Schneier FR, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [Abstract] [Full Text] [Related]

  • 23. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK, McDougle CJ, Price LH.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [Abstract] [Full Text] [Related]

  • 24. Management of treatment-refractory obsessive compulsive disorder patients.
    Dominguez RA, Mestre SM.
    J Clin Psychiatry; 1994 Oct; 55 Suppl():86-92. PubMed ID: 7961537
    [Abstract] [Full Text] [Related]

  • 25. Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder.
    Norman TR, Apostolopoulos M, Burrows GD, Judd FK.
    Int Clin Psychopharmacol; 1994 Oct; 9(2):89-94. PubMed ID: 8056999
    [Abstract] [Full Text] [Related]

  • 26. Fluoxetine-clomipramine interaction.
    Sternbach H.
    J Clin Psychiatry; 1995 Apr; 56(4):171-2. PubMed ID: 7713858
    [No Abstract] [Full Text] [Related]

  • 27. Fluoxetine-induced akathisia in male OCD patients.
    Friedman EH.
    J Clin Psychiatry; 1990 May; 51(5):212. PubMed ID: 2378629
    [No Abstract] [Full Text] [Related]

  • 28. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B, Bonnet-Perrin E.
    Encephale; 2001 May; 27(3):280-9. PubMed ID: 11488259
    [Abstract] [Full Text] [Related]

  • 29. [Efficacy assessment of fluoxetine treatment of outpatients with obsessive-compulsive disorder: a preliminary report].
    Wandzel L.
    Psychiatr Pol; 1997 May; 31(4):429-35. PubMed ID: 9527686
    [Abstract] [Full Text] [Related]

  • 30. Neuropsychological predictors of response to randomized treatment in obsessive-compulsive disorder.
    D'Alcante CC, Diniz JB, Fossaluza V, Batistuzzo MC, Lopes AC, Shavitt RG, Deckersbach T, Malloy-Diniz L, Miguel EC, Hoexter MQ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec 03; 39(2):310-7. PubMed ID: 22789662
    [Abstract] [Full Text] [Related]

  • 31. Serotonin syndrome from fluvoxamine and buspirone.
    Baetz M, Malcolm D.
    Can J Psychiatry; 1995 Sep 03; 40(7):428-9. PubMed ID: 8548727
    [No Abstract] [Full Text] [Related]

  • 32. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
    Liebowitz MR, Hollander E, Schneier F, Campeas R, Hatterer J, Papp L, Fairbanks J, Sandberg D, Davies S, Stein M.
    J Clin Psychopharmacol; 1989 Dec 03; 9(6):423-7. PubMed ID: 2687337
    [Abstract] [Full Text] [Related]

  • 33. Obsessive-compulsive disorder in HIV disease. Response to fluoxetine.
    McDaniel JS, Johnson KM.
    Psychosomatics; 1995 Dec 03; 36(2):147-50. PubMed ID: 7724717
    [No Abstract] [Full Text] [Related]

  • 34. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD, Birkett M, Koran L, Genduso L.
    J Clin Psychiatry; 1994 Oct 03; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [Abstract] [Full Text] [Related]

  • 35. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder.
    Geller DA, Biederman J, Reed ED, Spencer T, Wilens TE.
    J Am Acad Child Adolesc Psychiatry; 1995 Jan 03; 34(1):36-44. PubMed ID: 7860454
    [Abstract] [Full Text] [Related]

  • 36. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S.
    Fortschr Neurol Psychiatr; 1995 Jun 03; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract] [Full Text] [Related]

  • 37. Buspirone in obsessional compulsive disorder. A prospective case study.
    Farid BT, Bulto M.
    Pharmacopsychiatry; 1994 Sep 03; 27(5):207-9. PubMed ID: 7838892
    [Abstract] [Full Text] [Related]

  • 38. Open trial of fluoxetine in obsessive-compulsive disorder.
    Jenike MA, Buttolph L, Baer L, Ricciardi J, Holland A.
    Am J Psychiatry; 1989 Jul 03; 146(7):909-11. PubMed ID: 2787123
    [Abstract] [Full Text] [Related]

  • 39. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G.
    J Clin Psychiatry; 1995 Aug 03; 56(8):368-73. PubMed ID: 7635854
    [Abstract] [Full Text] [Related]

  • 40. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
    Koran LM, Cain JW, Dominguez RA, Rush AJ, Thiemann S.
    Am J Psychiatry; 1996 Nov 03; 153(11):1450-4. PubMed ID: 8890679
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.